U.S. Stock ETFs Brush Off Omicron Concerns | ETF Trends

U.S. markets and stock exchange traded funds gained for the third consecutive session on Thursday after data on COVID-19 infections revealed that the Omicron variant was less severe than feared.

On Thursday, the Invesco S&P 500 Equal Weight ETF (RSP), which follows the S&P 500 Equal Weight Index (EWI), rose 0.7%. Meanwhile, the S&P 500 was up 0.7%, the Dow Jones Industrial Average was 0.6% higher, and the Nasdaq Composite gained 1.0%.

United Kingdom healthcare data revealed that the Omicron variant may cause proportionally fewer hospital cases than the Delta variant, but public health experts still cautioned that the fight against the coronavirus pandemic is far from over, especially as revelers gather for the December festivities, Reuters reports.

Meanwhile, the U.S. Food and Drug Administration authorized the emergency use of Merck & Co’s antiviral COVID-19 pill after providing a green light to a similar treatment offered by Pfizer Inc. a day earlier.

“Last holiday season, there was an equal spike in cases, but now we have so many more weapons in our arsenal to fight COVID-19 and that is a very different outlook,” Christopher Grisanti, chief equity strategist at MAI Capital Management, told Reuters. “The Merck approval is a good example of that.”

Further adding to the risk-on mood, data from the Commerce Department revealed that ​​U.S. consumer spending for November was up 0.6% from the prior month, the Wall Street Journal reports.

The U.S. personal-consumption expenditures price index, excluding food and energy, for November, which is a gauge of inflation, was 4.7% higher year-over-year. Inflation has been a key focus with the Federal Reserve indicating that it will begin rolling back pandemic-era supportive policies.

“Inflation is center stage for a lot of people,” Andrew Cole, head of multiasset in London at Pictet Asset Management, told the WSJ. “Inflation is widely expected to peak, if not in the first quarter, the first half of next year. You might have to wait until the second half of next year for central banks to relax.”

For more news, information, and strategy, visit the Portfolio Strategies Channel.